Irritable Bowel Syndrome (IBS) Market 2019 Global Industry Analysis, Development, Revenue, Future Growth, Business Prospects and Forecast to 2024: Market Reports World

(The Express Wire via Comtex)

Worldwide Global Irritable Bowel Syndrome (IBS) Market 2019 Analysis Report audits a Market Regions, Product Categories, with Sales, Business Revenue, Goods cost, Global Irritable Bowel Syndrome (IBS) piece of the overall industry and Growth patterns, concentrating on driving Global Irritable Bowel Syndrome (IBS) industry players, showcase size, request and supply examination, utilization volume, Forecast 2019 to 2024.

Global “Irritable Bowel Syndrome (IBS) Market2019 Industry Research Report is a professional and in-depth study on the current state of the Global Irritable Bowel Syndrome (IBS) industry. Global Irritable Bowel Syndrome (IBS) Industry 2019 Market Research Report is spread across pages and provides exclusive vital statistics, data, information, trends and competitive landscape details in this niche sector.

Request a sample copy of the report -https://www.marketreportsworld.com/enquiry/request-sample/13102981

Short Details Irritable Bowel Syndrome (IBS) Market Report - Irritable bowel syndrome (IBS) is defined as recurrent abdominal pain or discomfort that occurs in association with altered bowel habits over a period of at least 3 months. The disorder is classified into three main subtypes, according to the predominant bowel habits presented: constipation-predominant IBS (IBS-C), diarrhea-predominant IBS (IBS-D), and mixed-presentation IBS (IBS-M). IBS is among the most common gastrointestinal disorders, with an estimated pooled international IBS prevalence rate of about 11.2%.

Global Irritable Bowel Syndrome (IBS) market competition by top manufacturers

  • Allergan
  • Valeant Pharmaceuticals
  • Takeda
  • Sucampo Pharmaceuticals
  • McNeil Consumer Healthcare
  • Sebela Pharmaceuticals
  • Astellas Pharmaceuticals
  • IM HealthScience

Enquire before purchasing this report -https://www.marketreportsworld.com/enquiry/pre-order-enquiry/13102981

Scope of the Report:

Currently, the IBS treatment market is naïve and underpenetrated, with 4 products indicated for IBS in the market. These include the IBS-C therapies, Amitiza (lubiprostone, Sucampo/Takeda) and Linzess (linaclotide, Ironwood/Allergan/Astellas); and the IBS-D therapies, Lotronex (Sebela Pharmaceuticals) and Irribow (ramosetron, Astellas). Antidepressants and antibiotics (mainly Xifaxan [rifaximin], Valeant) are also used off-label to treat IBS.
The IBS treatment market is characterized by significant unmet needs, which include the need for products with improved efficacy, products for the treatment of the IBS-D and IBS-M subtypes, and products that effectively address IBS symptoms, such as abdominal pain and bloating, as well as the requirement for the improved diagnosis of IBS. As a result, there are significant opportunities in the uncrowded IBS therapeutics market.
The worldwide market for Irritable Bowel Syndrome (IBS) is expected to grow at a CAGR of roughly 16.3% over the next five years, will reach 6530 million US$ in 2024, from 2640 million US$ in 2019, according to a new study.
This report focuses on the Irritable Bowel Syndrome (IBS) in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Purchase this report (Price 3480 USD for single user license) - https://www.marketreportsworld.com/purchase/13102981

By the product type, the market is primarily split into

  • Women
  • Men

By the end users/application, this report covers the following segments

  • Women
  • Men

Table of Contents

1 Market Overview

1.1 Irritable Bowel Syndrome (IBS) Introduction

1.2 Market Analysis by Type

1.3 Market Analysis by Applications

1.4 Market Analysis by Regions

1.4.1 North America (United States, Canada and Mexico)

1.4.1.1 United States Market States and Outlook (2014-2024)

1.4.1.2 Canada Market States and Outlook (2014-2024)

1.4.1.3 Mexico Market States and Outlook (2014-2024)

1.4.2 Europe (Germany, France, UK, Russia and Italy)

1.4.2.1 Germany Market States and Outlook (2014-2024)

1.4.2.2 France Market States and Outlook (2014-2024)

1.4.2.3 UK Market States and Outlook (2014-2024)

1.4.2.4 Russia Market States and Outlook (2014-2024)

1.4.2.5 Italy Market States and Outlook (2014-2024)

1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

1.4.3.1 China Market States and Outlook (2014-2024)

1.4.3.2 Japan Market States and Outlook (2014-2024)

1.4.3.3 Korea Market States and Outlook (2014-2024)

1.4.3.4 India Market States and Outlook (2014-2024)

1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)

1.4.4 South America, Middle East and Africa

1.4.4.1 Brazil Market States and Outlook (2014-2024)

1.4.4.2 Egypt Market States and Outlook (2014-2024)

1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)

1.4.4.4 South Africa Market States and Outlook (2014-2024)

1.4.4.5 Turkey Market States and Outlook (2014-2024)

1.5 Market Dynamics

1.5.1 Market Opportunities

1.5.2 Market Risk

1.5.3 Market Driving Force

2 Manufacturers Profiles

------------------------------------------------------------

3 Global Irritable Bowel Syndrome (IBS) Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)

3.1 Global Irritable Bowel Syndrome (IBS) Sales and Market Share by Manufacturer (2017-2018)

3.2 Global Irritable Bowel Syndrome (IBS) Revenue and Market Share by Manufacturer (2017-2018)

3.3 Market Concentration Rate

3.3.1 Top 3 Irritable Bowel Syndrome (IBS) Manufacturer Market Share in 2018

3.3.2 Top 6 Irritable Bowel Syndrome (IBS) Manufacturer Market Share in 2018

3.4 Market Competition Trend

4 Global Irritable Bowel Syndrome (IBS) Market Analysis by Regions

4.1 Global Irritable Bowel Syndrome (IBS) Sales, Revenue and Market Share by Regions

4.1.1 Global Irritable Bowel Syndrome (IBS) Sales and Market Share by Regions (2014-2019)

4.1.2 Global Irritable Bowel Syndrome (IBS) Revenue and Market Share by Regions (2014-2019)

4.2 North America Irritable Bowel Syndrome (IBS) Sales and Growth Rate (2014-2019)

4.3 Europe Irritable Bowel Syndrome (IBS) Sales and Growth Rate (2014-2019)

4.4 Asia-Pacific Irritable Bowel Syndrome (IBS) Sales and Growth Rate (2014-2019)

4.5 South America Irritable Bowel Syndrome (IBS) Sales and Growth Rate (2014-2019)

4.6 Middle East and Africa Irritable Bowel Syndrome (IBS) Sales and Growth Rate (2014-2019)

5 North America Irritable Bowel Syndrome (IBS) by Country

5.1 North America Irritable Bowel Syndrome (IBS) Sales, Revenue and Market Share by Country

5.1.1 North America Irritable Bowel Syndrome (IBS) Sales and Market Share by Country (2014-2019)

5.1.2 North America Irritable Bowel Syndrome (IBS) Revenue and Market Share by Country (2014-2019)

5.2 United States Irritable Bowel Syndrome (IBS) Sales and Growth Rate (2014-2019)

5.3 Canada Irritable Bowel Syndrome (IBS) Sales and Growth Rate (2014-2019)

5.4 Mexico Irritable Bowel Syndrome (IBS) Sales and Growth Rate (2014-2019)

------------------------------------------------------------

8 South America Irritable Bowel Syndrome (IBS) by Country

8.1 South America Irritable Bowel Syndrome (IBS) Sales, Revenue and Market Share by Country

8.1.1 South America Irritable Bowel Syndrome (IBS) Sales and Market Share by Country (2014-2019)

8.1.2 South America Irritable Bowel Syndrome (IBS) Revenue and Market Share by Country (2014-2019)

8.2 Brazil Irritable Bowel Syndrome (IBS) Sales and Growth Rate (2014-2019)

8.3 Argentina Irritable Bowel Syndrome (IBS) Sales and Growth Rate (2014-2019)

8.4 Colombia Irritable Bowel Syndrome (IBS) Sales and Growth Rate (2014-2019)

9 Middle East and Africa Irritable Bowel Syndrome (IBS) by Countries

9.1 Middle East and Africa Irritable Bowel Syndrome (IBS) Sales, Revenue and Market Share by Country

9.1.1 Middle East and Africa Irritable Bowel Syndrome (IBS) Sales and Market Share by Country (2014-2019)

9.1.2 Middle East and Africa Irritable Bowel Syndrome (IBS) Revenue and Market Share by Country (2014-2019)

9.2 Saudi Arabia Irritable Bowel Syndrome (IBS) Sales and Growth Rate (2014-2019)

9.3 Turkey Irritable Bowel Syndrome (IBS) Sales and Growth Rate (2014-2019)

9.4 Egypt Irritable Bowel Syndrome (IBS) Sales and Growth Rate (2014-2019)

9.5 Nigeria Irritable Bowel Syndrome (IBS) Sales and Growth Rate (2014-2019)

9.6 South Africa Irritable Bowel Syndrome (IBS) Sales and Growth Rate (2014-2019)

------------------------------------------------------------

11 Global Irritable Bowel Syndrome (IBS) Market Segment by Application

11.1 Global Irritable Bowel Syndrome (IBS) Sales Market Share by Application (2014-2019)

11.2 Home Using Sales Growth (2014-2019)

11.3 Hospital Using Sales Growth (2014-2019)

11.4 Other Sales Growth (2014-2019)

12 Irritable Bowel Syndrome (IBS) Market Forecast (2019-2024)

12.1 Global Irritable Bowel Syndrome (IBS) Sales, Revenue and Growth Rate (2019-2024)

12.2 Irritable Bowel Syndrome (IBS) Market Forecast by Regions (2019-2024)

12.2.1 North America Irritable Bowel Syndrome (IBS) Market Forecast (2019-2024)

12.2.2 Europe Irritable Bowel Syndrome (IBS) Market Forecast (2019-2024)

12.2.3 Asia-Pacific Irritable Bowel Syndrome (IBS) Market Forecast (2019-2024)

12.2.4 South America Irritable Bowel Syndrome (IBS) Market Forecast (2019-2024)

12.2.5 Middle East and Africa Irritable Bowel Syndrome (IBS) Market Forecast (2019-2024)

12.3 Irritable Bowel Syndrome (IBS) Market Forecast by Type (2019-2024)

12.3.1 Global Irritable Bowel Syndrome (IBS) Sales Forecast by Type (2019-2024)

12.3.2 Global Irritable Bowel Syndrome (IBS) Market Share Forecast by Type (2019-2024)

12.4 Irritable Bowel Syndrome (IBS) Market Forecast by Application (2019-2024)

12.4.1 Global Irritable Bowel Syndrome (IBS) Sales Forecast by Application (2019-2024)

12.4.2 Global Irritable Bowel Syndrome (IBS) Market Share Forecast by Application (2019-2024)

13 Sales Channel, Distributors, Traders and Dealers

13.1 Sales Channel

13.1.1 Direct Marketing

13.1.2 Indirect Marketing

13.1.3 Marketing Channel Future Trend

13.2 Distributors, Traders and Dealers

14 Research Findings and Conclusion

15 Appendix

15.1 Methodology

15.2 Data Source

Browse complete table of contents at -https://www.marketreportsworld.com/TOC/13102981

About Us:

Market Reports World is an upscale platform to help key personnel in the business world in strategic and taking visionary decisions based on facts and figures derived from in-depth market research. We are one of the top report re sellers in the market, dedicated to bringing you an ingenious concoction of data parameters.

Name: Ajay More

Email: [email protected]

Phone: US +14242530807/UK +442032398187

Our Other Report:
Smart Glasses Market : Smart Glasses Market report also covers in-depth description, competitive situation, wide product portfolio of prime players active during this market and business strategies adopted by competitors together with their SWOT analysis. The Smart Glasses Market report also provides Porter analysis, analysis and market attractiveness that helps to higher perceive the market situation on macro and small level. facet by facet.

Our Other Report:
Modular Homes Market : Modular Homes Market report passes on a survey of the Modular Homes Market including its definition, applications and innovation. Additionally, the Modular Homes Industry 2019 report explores the ecumenical Major Market players in detail. Modular Homes Market report gives key bits of erudition and subsisting status of the Modular Homes Players and is an imperative Source of course and heading for Companies and individuals roused by the Modular Homes Industry.

Press Release Distributed by The Express Wire

To view the original version on The Express Wire visit Irritable Bowel Syndrome (IBS) Market 2019 Global Industry Analysis, Development, Revenue, Future Growth, Business Prospects and Forecast to 2024: Market Reports World